MAI Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$263K Buy
+9,051
New +$240K ﹤0.01% 1619
2026
Q2
– Sell
-9,014
Closed -$125K – 2199
2026
Q1
$125K Buy
+9,014
New +$127K ﹤0.01% 1721

Other funds holding AMLX

MAI Capital Management's AMLX Position: Q3 2026 in Review

MAI Capital Management opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 9,051 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #1619 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in AMLX as recently as Q1 2026.

MAI Capital Management first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • MAI Capital Management held 9,051 shares of Amylyx Pharmaceuticals worth $263K as of Q3 2026.
  • Amylyx Pharmaceuticals was a new MAI Capital Management position in Q3 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q3 2026, its #1619 holding.
  • MAI Capital Management first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.